The changing face of post transplant lymphoproliferative disease in the era of preemptive EBV monitoring.

被引:0
|
作者
Kerkar, Nanda
Dugan, Christina
Karabicak, Ilhan
Miloh, Tamir
Moretti, Raffaella A.
Strauchen, James A.
Herold, Betsy
Shneider, Benjamin
Emre, Sulcru
机构
[1] Mt Sinai Sch Med, Div Hepatol Pediat & RMTI Surg, New York, NY USA
[2] Mt Sinai Sch Med, Dept Pathol, New York, NY USA
[3] Mt Sinai Sch Med, Dept Infect Dis, New York, NY USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
911
引用
收藏
页码:382 / 382
页数:1
相关论文
共 50 条
  • [31] Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease
    Bollard, CM
    Savoldo, B
    Rooney, CM
    Heslop, HE
    ACTA HAEMATOLOGICA, 2003, 110 (2-3) : 139 - 148
  • [32] EBV-PCR predicts susceptibility to post transplantation lymphoproliferative disease in pediatric heart transplant recipients
    Van Bergen, AH
    Hafemeyer, KL
    Herrington, CS
    Canter, CE
    Braunlin, EA
    CIRCULATION, 2001, 104 (17) : 677 - 677
  • [33] Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease
    Rohr, Jan C.
    Wagner, Hans J.
    Lauten, Melchior
    Wacker, Hans H.
    Juettner, Eva J.
    Hanke, Christof
    Pohl, Martin
    Niemeyer, Charlotte M.
    PEDIATRIC TRANSPLANTATION, 2008, 12 (04) : 426 - 431
  • [34] Autologous EBV-specific cytotoxic T cells to treat EBV-associated post-transplant lymphoproliferative disease (PTLD).
    Comoli, P
    Locatelli, F
    Gerna, G
    Grossi, P
    Vigano, M
    Maccario, R
    BLOOD, 1997, 90 (10) : 1097 - 1097
  • [35] Neurocomputing applications in post-operative liver transplant monitoring.
    Melvin, DG
    Niranjan, M
    Prager, RW
    Trull, AK
    Hughes, VF
    NEURAL NETWORKS FOR SIGNAL PROCESSING VII, 1997, : 216 - 225
  • [36] Prevalence and Characterization of EBV-Negative Post-Transplant Lymphoproliferative Disorder
    Ford, Maegan
    Jin, Zhezhen
    Orlando, Evelyn
    Lipsky, Andrew
    Sawas, Ahmed
    Pro, Barbara
    Amengual, Jennifer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S382 - S383
  • [37] Preemptive Rituximab Therapy of Epstein-Barr Virus (EBV) Infection to Prevent Post-Transplant Lymphoproliferative Disease (PTLD) After Pediatric Solid Organ Transplantation (SOT)
    Ahn, Y.
    Yi, N. -J.
    Min, S.
    Ha, I. -S.
    Cheong, H.
    Kang, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [38] Preemptive rituximab therapy of Epstein-Barr virus (EBV) infection to prevent post-transplant lymphoproliferative disease (PTLD) after pediatric solid organ transplantation (SOT)
    Ahn, Y. H.
    Lee, J. M.
    Yi, Nam-Joon
    Min, S. I.
    Kang, H. G.
    Ha, Il-Soo
    Cheong, H. I.
    Choi, Yong
    PEDIATRIC NEPHROLOGY, 2014, 29 (12) : 2442 - 2443
  • [39] EBV-positive post-transplant lymphoproliferative disorder: an unusual presentation
    Nfikha, Z.
    Abdessayed, N.
    Fejji, Y.
    Bchir, A.
    Sarra, Y.
    Chaieb, S.
    Mokni, M.
    VIRCHOWS ARCHIV, 2021, 479 : S219 - S219
  • [40] Prevalence and Characterization of EBV-Negative Post-Transplant Lymphoproliferative Disorder
    Ford, Maegan
    Orlando, Evelyn
    Jin, Zhezhen
    Lipsky, Andrew H.
    Sawas, Ahmed
    Pro, Barbara
    Amengual, Jennifer E.
    BLOOD, 2022, 140 : 3777 - 3778